scholarly article | Q13442814 |
P356 | DOI | 10.1056/NEJM198107093050201 |
P953 | full work available at URL | http://www.nejm.org/doi/pdf/10.1056/NEJM198107093050201 |
P698 | PubMed publication ID | 6264291 |
P2093 | author name string | A. B. Cosimi | |
P. S. Russell | |||
N. E. Tolkoff-Rubin | |||
R. H. Rubin | |||
M. S. Hirsch | |||
A. B. Collins | |||
R. T. McCluskey | |||
R. B. Colvin | |||
J. T. Herrin | |||
S. H. Cheeseman | |||
W. P. Richardson | |||
P2860 | cites work | The Raji cell radioimmune assay for detecting immune complexes in human sera | Q24563492 |
Cytomegalovirus: Clinical virological correlations in renal transplant recipients | Q27472812 | ||
Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effects on cytomegalovirus and herpes simplex virus infections | Q33397988 | ||
Immune Complexes in Congenital and Natal Cytomegalovirus Infections of Man | Q37047416 | ||
Epidemiology of Cytomegalovirus Infection after Transplantation and Immunosuppression | Q39957647 | ||
The Transplanted Kidney as a Source of Cytomegalovirus Infection | Q39958699 | ||
Transmission of cytomegalovirus infection with renal allograft | Q39969386 | ||
Infectious disease syndromes attributable to cytomegalovirus and their significance among renal transplant recipients | Q40120646 | ||
An Analysis of Cytomegalovirus Infection and HLA Antigen Matching on the Outcome of Renal Transplantation | Q40133297 | ||
From the National Institutes of Health. Summary of a workshop on cytomegalovirus infections during organ transplantation | Q40232299 | ||
Immune-complex Glomerulonephritis Associated with Cyton.egalovirus Infection | Q40235130 | ||
Association of renal allograft rejection with virus infections | Q40906023 | ||
Glomerular C3 receptors in human renal disease | Q41039923 | ||
Cryoglobulinemia and disease | Q43948100 | ||
Federation Proceedings | Q45106928 | ||
Viral syndromes and renal homograft rejection. | Q54702471 | ||
Viral Infection and Renal Transplant Rejection | Q57116330 | ||
Immune complex-mediated glomerulonephritis with infectious mononucleosis | Q68535083 | ||
Cytomegalovirus as a risk factor in renal transplantation | Q72880726 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Cytomegalovirus | Q6946 |
P304 | page(s) | 57-63 | |
P577 | publication date | 1981-07-01 | |
1981-07-09 | |||
P1433 | published in | The New England Journal of Medicine | Q582728 |
P1476 | title | Glomerulopathy Associated with Cytomegalovirus Viremia in Renal Allografts | |
P478 | volume | 305 |
Q42846833 | A Critical Appraisal of Methods to Grade Transplant Glomerulitis in Renal Allograft Biopsies |
Q44944424 | A Multivariate Analysis of Risk Factors for Cytomegalovirus Infection in Liver-Transplant Recipients |
Q43854940 | A case of persistent acute allograft glomerulopathy with long-standing stable renal function |
Q36635110 | Acquisition of cytomegalovirus infection: an update |
Q37247263 | Antibodies to cytomegalovirus in renal allograft recipients: correlation with isolation of virus |
Q35917546 | Antimicrobial prophylaxis in solid-organ transplantation. |
Q67260044 | Association of Herpesvirus Infections with T-Lymphocyte-Subset Alterations, Glomerulopathy, and Opportunistic Infections after Renal Transplantation |
Q33337686 | BMT: Bone Marrow Transplant Associated Thrombotic Microangiopathy |
Q40464538 | Chronic renal transplant loss |
Q39179951 | Clinical applications of monoclonal antibodies in renal allograft biopsies |
Q39789792 | Comparison of LightCycler-based PCR, COBAS amplicor CMV monitor, and pp65 antigenemia assays for quantitative measurement of cytomegalovirus viral load in peripheral blood specimens from patients after solid organ transplantation |
Q71568703 | Correlation between Banff classification, acute renal rejection scores and reversal of rejection |
Q38843499 | Current status of pediatric renal transplant pathology |
Q42235317 | Cytomegalovirus glomerulopathy and cytomegalovirus interstitial nephritis on sequential transplant kidney biopsies. |
Q70138483 | Cytomegalovirus glomerulopathy: a controversial lesion |
Q38487366 | Cytomegalovirus in the transplanted kidney: a report of two cases and review of prophylaxis. |
Q43677913 | Cytomegalovirus infection and pneumonitis. Impact after isolated lung transplantation. Washington University Lung Transplant Group |
Q35962177 | Cytomegalovirus infection in the liver transplant recipient. Epidemiology, pathogenesis, and clinical management |
Q73619601 | Cytomegalovirus infection induces anti-endothelial cell antibodies in cardiac and renal allograft recipients |
Q44645546 | Cytomegalovirus infection of human kidney cells in vitro |
Q44676762 | Cytomegalovirus infection-enhanced chronic kidney allograft rejection is linked with intercellular adhesion molecule-1 expression |
Q43070492 | Cytomegalovirus infections in renal transplant recipients |
Q38960187 | Cytomegalovirus-Responsive CD8+ T Cells Expand After Solid Organ Transplantation in the Absence of CMV Disease. |
Q74681888 | Cytomegalovirus-induced glomerular vasculopathy in renal allografts: a report of two cases |
Q72042776 | De novo immunotactoid glomerulopathy of the renal allograft: possible association with cytomegalovirus infection |
Q44070881 | Differential diagnosis of acute allograft rejection and CMV-infection in renal transplantation by urinary cytology |
Q35584555 | Disseminated cytomegalovirus infection. Molecular analysis of virus and leukocyte interactions in viremia |
Q67297418 | Effects of Interferon-Alpha on Cytomegalovirus Reactivation Syndromes in Renal-Transplant Recipients |
Q70293571 | Factors contributing for improved graft survival in recipients of kidney transplants |
Q36425945 | Genomic localization, sequence analysis, and transcription of the putative human cytomegalovirus DNA polymerase gene |
Q63979957 | Glomerular Lesions in the Transplanted Kidney in Children |
Q70147968 | Glomerulonephritis in congenital cytomegalic inclusion disease |
Q34488792 | HLA-DRw6 as a risk factor for active cytomegalovirus but not for herpes simplex virus infection after renal allograft transplantation |
Q35608425 | High levels of circulating cytomegalovirus DNA reflect visceral organ disease in viremic immunosuppressed patients other than marrow recipients |
Q33418900 | Hyperimmune globulin therapy of clinical cytomegalovirus infection in renal allograft recipients |
Q72795385 | Immunological monitoring of diabetic and nondiabetic recipients of renal allografts |
Q33854964 | Implication of gammadelta T cells in the human immune response to cytomegalovirus |
Q67274391 | Increased IgM and IgM immune complex-like material in the circulation of renal transplant recipients with primary cytomegalovirus infections |
Q34294779 | Infection in solid organ transplantation. |
Q34807471 | Infections and solid organ transplant rejection: a cause-and-effect relationship? |
Q43554840 | Infections in Organ Transplant Recipients |
Q34379808 | Infections in recipients of kidney transplants |
Q35376486 | Infections in solid-organ transplant recipients |
Q40856911 | Infectious disease complications of renal transplantation |
Q36048241 | Infiltration of Macrophages Correlates with Severity of Allograft Rejection and Outcome in Human Kidney Transplantation |
Q34354852 | International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology |
Q70110733 | Interstitial nephritis associated with cytomegalovirus infection |
Q70688940 | Is kidney the real dose-limiting organ after total body irradiation and bone marrow transplantation? |
Q50910864 | It's not too late: a proposal to standardize the terminology of "late-onset" cytomegalovirus infection and disease in solid organ transplant recipients. |
Q33839808 | Lack of association between cytomegalovirus infection of heart and rejection-like inflammation |
Q43887678 | Lack of association between cytomegalovirus infection, HLA matching and the vanishing bile duct syndrome after liver transplantation |
Q44569078 | Maintenance of cytomegalovirus (CMV) latency and host immune responses of long term renal allograft survivors. II. Secondary CMV infections associated with impaired in vitro proliferative responses to mitogens, allogeneic lymphocytes and CMV infecte |
Q35235567 | Management and prevention of cytomegalovirus infection after renal transplantation |
Q34271684 | Management of cytomegalovirus infection and disease after solid-organ transplantation |
Q41351279 | Management of cytomegalovirus infection in solid-organ transplant recipients |
Q37565855 | Monocytes/macrophages in renal allograft rejection |
Q35856256 | Mononuclear cells in acute allograft glomerulopathy. |
Q41933718 | Neonatal cytomegalovirus infection with pancreatic cystadenoma and nephrotic syndrome |
Q67236233 | Neutralization and sensitization of cytomegalovirus by IgG antibody, anti-IgG antibody, and complement |
Q40851368 | New developments in cytomegalovirus prevention and management. |
Q33812425 | New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients |
Q50584444 | Outbreak of Kaposi's sarcoma with cytomegalovirus infection in young homosexual men |
Q37358692 | Pancreatic anastomosis leak 15 years after simultaneous pancreas-kidney transplantation from late-onset allograft cytomegalovirus duodenal ulcers presenting with gross hematuria |
Q36843425 | Pauci-immune and immune glomerular lesions in kidney transplants for systemic lupus erythematosus. |
Q70803996 | Persistent Problems with Persistent Herpesviruses |
Q44319196 | Pharmacoeconomic analysis of preemptive gancyclovir therapy in the prevention of cytomegalovirus infections in high-risk renal graft recipients |
Q40199674 | Polymerase chain reaction assay for detection of human cytomegalovirus. |
Q54229714 | Post-transplantation nephrosis in congenital nephrotic syndrome of the Finnish type. |
Q72125084 | Presence of cytomegalovirus genome and leucocyte subsets in renal transplant biopsies. Relationship with prognosis |
Q67915468 | Preservation of natural endothelial cytopathogenicity of cytomegalovirus by propagation in endothelial cells |
Q73353458 | Prevalence of hepatitis C in patients with idiopathic glomerulopathies in native and transplant kidneys |
Q37176362 | Prevention of cytomegalovirus infection in the pediatric renal transplant recipient |
Q35885992 | Progressive cytomegalovirus glomerulonephritis - An experimental model |
Q37182018 | Prospective study of the human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipients |
Q72066709 | Quantification of low frequency white blood cells expressing human cytomegalovirus antigen by image cytometry |
Q37211704 | Rapid detection of cytomegalovirus in clinical specimens by using biotinylated DNA probes and analysis of cross-reactivity with herpes simplex virus |
Q39526508 | Recent developments in dialysis and transplantation |
Q37177362 | Recovery of human immunodeficiency virus type 1 from supernatant fluid of routine viral cultures |
Q74332978 | Renal Doppler sonographic and histologic findings in post-transplant primary cytomegalovirus disease |
Q73181330 | Renal allograft dysfunction associated with cytomegalovirus infection |
Q69910754 | Renal deposition of cytomegalovirus antigen in immunoglobulin-A nephropathy |
Q45175430 | Renal failure in the course of reactivation of varicella-zoster virus infection in a renal transplant recipient |
Q34995543 | Renal graft dysfunction during infection with cytomegalovirus: association with IgM lymphocytotoxins and HLA-DR3 and DR7 |
Q70256893 | Renal transplantation in children |
Q67848187 | Reversal of acute glomerular renal allograft rejection: a possible effect of OKT3 |
Q41631415 | Role of electron microscopy in transplant renal pathology |
Q36805250 | Role of primary and secondary maternal viremia in transplacental guinea pig cytomegalovirus transfer. |
Q83828789 | Spectrum of cytomegalovirus-induced renal pathology in renal allograft recipients |
Q40173271 | Status of Renal Transplantation: A Clinical Perspective |
Q37773992 | Strategies for managing cytomegalovirus in transplant recipients |
Q38779938 | The Cell Biology of Cytomegalovirus: Implications for Transplantation |
Q73091074 | The effects of cytomegalovirus serology on graft and recipient survival in cadaveric renal transplantation: implications for organ allocation |
Q35143349 | The human cytomegalovirus. |
Q41168688 | The renal allograft biopsy |
Q67263418 | The value of needle renal allograft biopsy. I. A retrospective study of biopsies performed during putative rejection episodes |
Q43507137 | Three-year outcome of isolated glomerulitis on 3-month protocol biopsies of donor HLA antibody negative patients |
Q72573704 | Towne-vaccine-induced prevention of cytomegalovirus disease after renal transplants |
Q73598692 | Transplant glomerulopathy as a cause of late graft loss |
Q69901036 | Transplant glomerulopathy: evolution of morphologically distinct changes |
Q67287983 | Tubulo-Interstitial Nephritis Associated with Polyomavirus (BK Type) Infection |
Q40683631 | Tubulointerstitial nephritis: diagnosis, treatment, and monitoring |
Q73712477 | Type I membranoproliferative glomerulonephritis in a renal allograft: A recurrence induced by a cytomegalovirus infection? |
Q71338090 | Ultrastructural immunohistochemistry of glomerulonephritis in needle biopsy |
Q40214747 | Use of a modified shell vial technique to quantitate cytomegalovirus viremia in a population of solid-organ transplant recipients |
Q70258917 | Viral Infection and T-Lymphocyte Subpopulations in Renal-Transplant Recipients |
Search more.